Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 31

    1.

    Differences in Clinical Trial Patient Attributes and Outcomes According to Enrollment Setting.

    Lamont EB, Landrum MB, Keating NL, Archer L, Lan L, Strauss GM, Lilenbaum R, Niell HB, Maurer LH, Kosty MP, Miller AA, Clamon GH, Elias AD, McClay EF, Vokes EE, McNeil BJ.

    J Clin Oncol. 2009 Nov 23. [Epub ahead of print]PMID: 19933919 [PubMed - as supplied by publisher]

    2.

    Paradoxes in Advance Care Planning: The Complex Relationship of Oncology Patients, Their Physicians, and Advance Medical Directives.

    Dow LA, Matsuyama RK, Ramakrishnan V, Kuhn L, Lamont EB, Lyckholm L, Smith TJ.

    J Clin Oncol. 2009 Nov 23. [Epub ahead of print]PMID: 19933909 [PubMed - as supplied by publisher]

    3.

    Utility of administrative claims data for the study of brain metastases: a validation study.

    Eichler AF, Lamont EB.

    J Neurooncol. 2009 Dec;95(3):427-31. Epub 2009 Jun 27.PMID: 19562256 [PubMed - in process]Related articles

    4.

    Extent and determinants of error in physicians' prognoses in terminally ill patients: prospective cohort study.

    Christakis NA, Lamont EB.

    West J Med. 2000 May;172(5):310-313.PMID: 18751282 [PubMed - as supplied by publisher]Related articlesFree article

    5.

    Secular changes in NSAID use and invasive colorectal cancer incidence: an ecological study.

    Lamont EB, Dias LE.

    Cancer J. 2008 Jul-Aug;14(4):276-7. No abstract available. PMID: 18677138 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Evaluation of trends in the cost of initial cancer treatment.

    Warren JL, Yabroff KR, Meekins A, Topor M, Lamont EB, Brown ML.

    J Natl Cancer Inst. 2008 Jun 18;100(12):888-97. Epub 2008 Jun 10.PMID: 18544740 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Oncogenic osteomalacia as a harbinger of recurrent osteosarcoma.

    Lamont EB, Cavaghan MK, Brockstein BE.

    Sarcoma. 1999;3(2):95-9.PMID: 18521270 [PubMed - in process]Related articlesFree article

    8.

    Cost of care for elderly cancer patients in the United States.

    Yabroff KR, Lamont EB, Mariotto A, Warren JL, Topor M, Meekins A, Brown ML.

    J Natl Cancer Inst. 2008 May 7;100(9):630-41. Epub 2008 Apr 29.PMID: 18445825 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Measuring clinically significant chemotherapy-related toxicities using Medicare claims from Cancer and Leukemia Group B (CALGB) trial participants.

    Lamont EB, Herndon JE 2nd, Weeks JC, Henderson IC, Lilenbaum R, Schilsky RL, Christakis NA; Cancer and Leukemia Group B.

    Med Care. 2008 Mar;46(3):303-8.PMID: 18388845 [PubMed - indexed for MEDLINE]Related articles

    10.

    NSAIDs and colorectal cancer risk: do administrative data support a chemopreventive effect?

    Lamont EB, Dias LE, Lauderdale DS.

    J Gen Intern Med. 2007 Aug;22(8):1166-71. Epub 2007 Jun 19.PMID: 17577606 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Patient time costs associated with cancer care.

    Yabroff KR, Davis WW, Lamont EB, Fahey A, Topor M, Brown ML, Warren JL.

    J Natl Cancer Inst. 2007 Jan 3;99(1):14-23.PMID: 17202109 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Measuring disease-free survival and cancer relapse using Medicare claims from CALGB breast cancer trial participants (companion to 9344).

    Lamont EB, Herndon JE 2nd, Weeks JC, Henderson IC, Earle CC, Schilsky RL, Christakis NA; Cancer and Leukemia Group B.

    J Natl Cancer Inst. 2006 Sep 20;98(18):1335-8. Erratum in: J Natl Cancer Inst. 2006 Nov 1;98(21):1584. J Natl Cancer Inst. 2008 Jan 2;100(1):70. PMID: 16985253 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Cancer and leukemia group B cancer control and health outcomes committee: origins and accomplishments.

    Paskett ED, Schrag D, Kornblith A, Lamont EB, Weeks JC, Marshall JR, Shapiro C, Holland J.

    Clin Cancer Res. 2006 Jun 1;12(11 Pt 2):3601s-5s. Review.PMID: 16740792 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    A demographic and prognostic approach to defining the end of life.

    Lamont EB.

    J Palliat Med. 2005;8 Suppl 1:S12-21. Review.PMID: 16499460 [PubMed - indexed for MEDLINE]Related articles

    16.

    Criterion validity of Medicare chemotherapy claims in Cancer and Leukemia Group B breast and lung cancer trial participants.

    Lamont EB, Herndon JE 2nd, Weeks JC, Henderson IC, Lilenbaum R, Schilsky RL, Christakis NA.

    J Natl Cancer Inst. 2005 Jul 20;97(14):1080-3.PMID: 16030306 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Paradoxes in cancer patients' advance care planning.

    Lamont EB, Siegler M.

    J Palliat Med. 2000 Spring;3(1):27-35.PMID: 15859719 [PubMed]Related articles

    18.

    Patterns of presentation, diagnosis, and treatment in older patients with colon cancer and comorbid dementia.

    Gupta SK, Lamont EB.

    J Am Geriatr Soc. 2004 Oct;52(10):1681-7.PMID: 15450045 [PubMed - indexed for MEDLINE]Related articles

    19.

    Low risk of hip fracture among elderly breast cancer survivors.

    Lamont EB, Lauderdale DS.

    Ann Epidemiol. 2003 Nov;13(10):698-703.PMID: 14599734 [PubMed - indexed for MEDLINE]Related articles

    20.

    Is patient travel distance associated with survival on phase II clinical trials in oncology?

    Lamont EB, Hayreh D, Pickett KE, Dignam JJ, List MA, Stenson KM, Haraf DJ, Brockstein BE, Sellergren SA, Vokes EE.

    J Natl Cancer Inst. 2003 Sep 17;95(18):1370-5.PMID: 13130112 [PubMed - indexed for MEDLINE]Related articlesFree article

    21.

    Complexities in prognostication in advanced cancer: "to help them live their lives the way they want to".

    Lamont EB, Christakis NA.

    JAMA. 2003 Jul 2;290(1):98-104.PMID: 12837717 [PubMed - indexed for MEDLINE]Related articles

    22.

    Favorable cardiac risk among elderly breast carcinoma survivors.

    Lamont EB, Christakis NA, Lauderdale DS.

    Cancer. 2003 Jul 1;98(1):2-10.PMID: 12833448 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    Effectiveness of adjuvant fluorouracil in clinical practice: a population-based cohort study of elderly patients with stage III colon cancer.

    Iwashyna TJ, Lamont EB.

    J Clin Oncol. 2002 Oct 1;20(19):3992-8.PMID: 12351596 [PubMed - indexed for MEDLINE]Related articles

    24.

    Physician factors in the timing of cancer patient referral to hospice palliative care.

    Lamont EB, Christakis NA.

    Cancer. 2002 May 15;94(10):2733-7.PMID: 12173344 [PubMed - indexed for MEDLINE]Related articles

    25.

    Chemotherapy in the management of squamous-cell carcinoma of the head and neck.

    Lamont EB, Vokes EE.

    Lancet Oncol. 2001 May;2(5):261-9. Review.PMID: 11905780 [PubMed - indexed for MEDLINE]Related articles

    26.

    Construct validity of medicare chemotherapy claims: the case of 5FU.

    Lamont EB, Lauderdale DS, Schilsky RL, Christakis NA.

    Med Care. 2002 Mar;40(3):201-11.PMID: 11880793 [PubMed - indexed for MEDLINE]Related articles

    27.

    Prognostic disclosure to patients with cancer near the end of life.

    Lamont EB, Christakis NA.

    Ann Intern Med. 2001 Jun 19;134(12):1096-105.PMID: 11412049 [PubMed - indexed for MEDLINE]Related articlesFree article

    28.

    Extent and determinants of error in doctors' prognoses in terminally ill patients: prospective cohort study.

    Christakis NA, Lamont EB.

    BMJ. 2000 Feb 19;320(7233):469-72.PMID: 10678857 [PubMed - indexed for MEDLINE]Related articlesFree article

    29.

    The oral fluoropyrimidines in cancer chemotherapy.

    Lamont EB, Schilsky RL.

    Clin Cancer Res. 1999 Sep;5(9):2289-96. Review.PMID: 10499595 [PubMed - indexed for MEDLINE]Related articlesFree article

    30.

    Some elements of prognosis in terminal cancer.

    Lamont EB, Christakis NA.

    Oncology (Williston Park). 1999 Aug;13(8):1165-70; discussion 1172-4, 1179-80. Review.PMID: 10499248 [PubMed - indexed for MEDLINE]Related articles

    31.

    An occult cause of persistent nausea and vomiting.

    Lamont EB, Sayah A.

    J Emerg Med. 1997 Sep-Oct;15(5):633-5.PMID: 9348050 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...